Hydroxyurea (Biosupressin-BIOGAL) for the treatment of chronic myelogenous leukaemia.
D000328:Adult; D000368:Aged; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use*; D007951:Leukemia, Myeloid / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged
D006918:Hydroxyurea